We are research team that covers wide spectrum of financial assets in USA, Europe and across emerging markets. We primarily focus on short-to-medium duration bonds and event-driven equity strategies.
Recently, our team decided to publish some of our Fixed Income/Event-Driven investment insights here on Seeking Alpha. Our goal is to represent ourselves to different kind of investors as well as attract attention of larger financial institutions for future cooperation.
We are committed to provide you only the best ideas, insights and analysis.
We also welcome your feedback on our investment insights as well as your own ideas!
Feel free to subscribe to our channel and use our knowledge and experience for making return on your own investments. Welcome to Lighthouse Research!
Disclaimer: please note that provided views and materials cannot be classified as investment recommendations from legal point of view. Provided insights must not be used on their own for making investment decisions. Investors are recommended to do their own research and consult with their broker(s)/investment advisor(s) prior to making a trade. Investing in financial assets always poses a risk of capital loss.
Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (“IBI) marketplace research is delivering robust returns since inceptions. To name a few winners, Nektar Therapeutics procured over 446% profits while Spectrum Pharmaceuticals delivered over 196% gains. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios. Of note, we’ll increase our price soon (SUBSCRIBE to IBI now to lock in the current price and save money). Click the orange FOLLOW button to receive the FREE real-time alerts on our articles and blogs. To read the FREE once-weekly articles covering promising small-cap bioscience firms, check out www.drtranbiosci.com (and make sure to register for our mailing list). You can read up on Dr. Tran’s background in an in-depth article by following this link. http://www.drtranbiosci.com/p/dr-tran.html "Stellar therapeutics for patients. Differentiated intelligence for investors. Premium valuations for firms."
Founded in 2013 by Jordan Ring, JGR Capital addresses the challenges that are unique to the small-cap niche, presenting high-quality analysis to investors and shareholders, who are increasingly looking to diversify their portfolio.
With three locations worldwide, JGR Capital offers analyst coverage via a tech-forward, data-driven approach. Because our reports are based on facts, not recommendations, we are a reputable, trusted resource for investors.
Automated Information Systems - Since 1998, we have offered our customers, broad based automated information systems solutions in the form of software development, system integration, the best-selected components from industry leading manufacturers, and unique custom designed hardware for specific applications.